SCHEMBL5482346

SCHEMBL5482346

O=C(c1ccc(F)cc1)[C@H]1CCCN(C(=O)c2ccc3ccccc3n2)C1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.54
KDM4E B2RXH2 4/20 0.54
KDM2B Q8NHM5 2/20 0.53
PLA2G1B P04054 2/20 0.52
ATG4B Q9Y4P1 2/20 0.52
HTT P42858 3/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
MAPT P10636 3/20 0.48
PKM P14618 2/20 0.48
POLB P06746 1/20 0.48
BLM P54132 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPK1 P28482 1/20 0.48
RAB9A P51151 1/20 0.48
HSD11B1 P28845 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 1/20 0.47
HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5482339 1.00 ALDH1A1 (0.54) ALDH1A1KDM4EKDM2BPLA2G1BATG4B
SCHEMBL5475839 0.94 HSD11B1 (0.55) KDM4EKMT2APOLBMAPK1RAB9A
SCHEMBL5475835 0.94 HSD11B1 (0.55) KDM4EKMT2APOLBMAPK1RAB9A
SCHEMBL6210071 0.87 HSD11B1 (0.64) KDM4EKMT2APOLBHSD11B1LMNA
SCHEMBL5478237 0.81 PLA2G1B (0.75) ALDH1A1KDM4EPLA2G1BATG4BMEN1
SCHEMBL5478240 0.81 PLA2G1B (0.75) ALDH1A1KDM4EPLA2G1BATG4BMEN1
SCHEMBL5480054 0.81 KDM2B (0.58) ALDH1A1KDM4EKDM2BHTTMEN1
SCHEMBL5480051 0.81 KDM2B (0.58) ALDH1A1KDM4EKDM2BHTTMEN1
SCHEMBL21928849 0.81 HSD11B1 (0.71) ALDH1A1MEN1KMT2AMAPK1RAB9A
SCHEMBL5474315 0.80 HSD11B1 (0.68) ALDH1A1KDM4EMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112000-A1 Chemical compounds ASTRAZENECA R&D ALDERLEY (GB) 2007-05-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112000-A1 Chemical compounds HSD11B1, CYP11B1, HSD11B2 ALDH1A1 68/4885KDM4E 1816/4885KDM2B 1673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.